Skip to main content
. 2022 Jul 12;2022(7):CD010834. doi: 10.1002/14651858.CD010834.pub4
Database/search platform/date of last search Search strategy
Airways Register (via Cochrane Register of Studies)
Date of most recent search: 7 February 2022 #1 AST:MISC1
#2 MeSH DESCRIPTOR Asthma Explode All
#3 asthma*:ti,ab
#4 #1 or #2 or #3
#5 MeSH DESCRIPTOR Antibodies, Monoclonal
#6 MeSH DESCRIPTOR Antibodies, Monoclonal, Humanized
#7 human* NEAR2 monoclonal* NEAR2 antibod*
#8 mepolizumab
#9 SB24056 or SB‐24056
#10 Bosatria or Nucala
#11 benralizumab*
#12 MEDI‐563
#13 reslizumab*
#14 Cinquil or Cinqair
#15 CEP‐38072
#16 "anti‐interleukin 5"
#17 "anti‐IL5"
#18 "anti‐IL‐5"
#19 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18
#20 #4 AND #19
CENTRAL (via Cochrane Register of Studies)
Date of most recent search: 7 February 2022 #1 AST:MISC1
#2 MeSH DESCRIPTOR Asthma Explode All
#3 asthma*:ti,ab
#4 #1 or #2 or #3
#5 MeSH DESCRIPTOR Antibodies, Monoclonal
#6 MeSH DESCRIPTOR Antibodies, Monoclonal, Humanized
#7 human* NEAR2 monoclonal* NEAR2 antibod*
#8 mepolizumab
#9 SB24056 or SB‐24056
#10 Bosatria or Nucala
#11 benralizumab*
#12 MEDI‐563
#13 reslizumab*
#14 Cinquil or Cinqair
#15 CEP‐38072
#16 "anti‐interleukin 5"
#17 "anti‐IL5"
#18 "anti‐IL‐5"
#19 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18
#20 #4 AND #19
MEDLINE (Ovid) ALL
Date of most recent search: 7 February 2022 1 exp asthma/
2 asthma*.tw.
3 1 or 2
4 Antibodies, Monoclonal, Humanized/tu [Therapeutic Use]
5 mepolizumab.tw.
6 (Bosatria or Nucala).tw.
7 benralizumab.tw.
8 MEDI‐563.tw.
9 reslizumab.tw.
10 (Cinquil or Cinqair).tw.
11 CEP‐38072.tw.
12 "anti‐interleukin 5".tw.
13 "anti‐IL5".tw.
14 "anti‐IL‐5".tw.
15 or/4‐14
16 3 and 15
17 (controlled clinical trial or randomized controlled trial).pt.
18 (randomized or randomised).ab,ti.
19 placebo.ab,ti.
20 dt.fs.
21 randomly.ab,ti.
22 trial.ab,ti.
23 groups.ab,ti.
24 or/17‐23
25 Animals/
26 Humans/
27 25 not (25 and 26)
28 24 not 27
29 16 and 28
Embase (Ovid)
Date of most recent search: 7 February 2022 1 exp asthma/
2 asthma$.tw.
3 1 or 2
4 mepolizumab/
5 mepolizumab.tw.
6 (Bosatria or Nucala).tw.
7 benralizumab.tw.
8 MEDI‐563.tw.
9 benralizumab/
10 reslizumab/
11 (Cinquil or Cinqair).tw.
12 CEP‐38072.tw.
13 "anti‐interleukin 5".tw.
14 "anti‐IL5".tw.
15 "anti‐IL‐5".tw.
16 or/4‐15
17 Randomized Controlled Trial/
18 randomization/
19 controlled clinical trial/
20 Double Blind Procedure/
21 Single Blind Procedure/
22 Crossover Procedure/
23 (clinica$ adj3 trial$).tw.
24 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (mask$ or blind$ or method$)).tw.
25 exp Placebo/
26 placebo$.ti,ab.
27 random$.ti,ab.
28 ((control$ or prospectiv$) adj3 (trial$ or method$ or stud$)).tw.
29 (crossover$ or cross‐over$).ti,ab.
30 or/17‐29
31 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/
32 human/ or normal human/ or human cell/
33 31 and 32
34 31 not 33
35 30 not 34
36 16 and 35
ClinicalTrials.gov
Date of most recent search: 7 February 2022 Study type: interventional
Condition: asthma
Intervention: mepolizumab or reslizumab or benralizumab
WHO trials portal
Date of most recent search: 7 February 2022 Condition: asthma
Intervention: mepolizumab or reslizumab or benralizumab